Share
Other content recommended for you
- Ataxia with oculomotor apraxia type 2: an evolving axonal neuropathy
- Vitamin D supplementation
- Vitamin D levels in Malawian infants from birth to 24 months
- Heterozygous deletion in exon 6 of STEX gene causing ataxia with oculomotor apraxia type 2 (AOA-2) with ovarian failure
- Autosomal recessive cerebellar ataxias: the current state of affairs
- Genetically predicted serum vitamin D and COVID-19: a Mendelian randomisation study
- Complete deletion of the aprataxin gene: ataxia with oculomotor apraxia type 1 with severe phenotype and cognitive deficit
- Golden opportunity for intervention? Identifying vitamin D deficiency in patients with substance use disorders in hospital
- Association between blood circulating vitamin D and colorectal cancer risk in Asian countries: a systematic review and dose-response meta-analysis
- Vitamin D level in patients with systemic lupus erythematosus: its relationship to disease course and bone mineral density